AAAAAA

   
Results: 1-8 |
Results: 8
LOW-DOSE INTRAVENOUS BOLUS INTERLEUKIN-2 WITH INTERFERON-ALPHA THERAPY FOR METASTATIC MELANOMA AND RENAL-CELL CARCINOMA
Authors: KARP SE
Citation: Se. Karp, LOW-DOSE INTRAVENOUS BOLUS INTERLEUKIN-2 WITH INTERFERON-ALPHA THERAPY FOR METASTATIC MELANOMA AND RENAL-CELL CARCINOMA, Journal of immunotherapy, 21(1), 1998, pp. 56-61
GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER
Authors: FOULKES WD WONG N BRUNET JS BEGIN LR ZHANG JC MARTINEZ JJ ROZEN F TONIN PN NAROD SA KARP SE POLLAK MN
Citation: Wd. Foulkes et al., GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER, Clinical cancer research, 3(12), 1997, pp. 2465-2469
GENERATION OF THERAPEUTIC T-CELLS FROM DRAINING LYMPH-NODES IN A MURINE MODEL OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: SADEGHI N BLACK MJ HIER MP SHENOUDA G KARP SE
Citation: N. Sadeghi et al., GENERATION OF THERAPEUTIC T-CELLS FROM DRAINING LYMPH-NODES IN A MURINE MODEL OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Archives of otolaryngology, head & neck surgery, 123(1), 1997, pp. 25-30
INFLUENCE OF BRCA1 MUTATIONS ON NUCLEAR GRADE AND ESTROGEN-RECEPTOR STATUS OF BREAST-CARCINOMA IN ASHKENAZI JEWISH WOMEN
Authors: KARP SE TONIN PN BEGIN LR MARTINEZ JJ ZHANG JC POLLAK MN FOULKES WD
Citation: Se. Karp et al., INFLUENCE OF BRCA1 MUTATIONS ON NUCLEAR GRADE AND ESTROGEN-RECEPTOR STATUS OF BREAST-CARCINOMA IN ASHKENAZI JEWISH WOMEN, Cancer, 80(3), 1997, pp. 435-441
GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER
Authors: WONG N BRUNET JS BEGIN LR ZHANG JC MARTINEZ JJ TONIN PN NAROD SA KARP SE POLLAK MN FOULKES WD
Citation: N. Wong et al., GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER, American journal of human genetics, 61(4), 1997, pp. 490-490
A MURINE MODEL FOR THE IMMUNOTHERAPY OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: HIER MP BLACK MJ SHENOUDA G SADEGHI N KARP SE
Citation: Mp. Hier et al., A MURINE MODEL FOR THE IMMUNOTHERAPY OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA, The Laryngoscope, 105(10), 1995, pp. 1077-1080
STIMULATION OF ANTITUMOR IMMUNITY BY TGF-BETA GENETIC-MODIFICATION OFMURINE TUMOR TO EXPRESS TGF-BETA INDUCES TUMOR-REGRESSION
Authors: KARP SE CHAN HL HIER MP
Citation: Se. Karp et al., STIMULATION OF ANTITUMOR IMMUNITY BY TGF-BETA GENETIC-MODIFICATION OFMURINE TUMOR TO EXPRESS TGF-BETA INDUCES TUMOR-REGRESSION, Journal of cellular biochemistry, 1994, pp. 114-114
RETROVIRAL TRANSDUCTION OF INTERFERON-GAMMA CDNA INTO A NONIMMUNOGENIC MURINEFIBROSARCOMA - GENERATION OF T-CELLS IN DRAINING LYMPH-NODES CAPABLE OF TREATING ESTABLISHED PARENTAL METASTATIC TUMOR
Authors: SHILONI E KARP SE CUSTER MC SHILYANSKY J RESTIFO NP ROSENBERG SA MULE JJ
Citation: E. Shiloni et al., RETROVIRAL TRANSDUCTION OF INTERFERON-GAMMA CDNA INTO A NONIMMUNOGENIC MURINEFIBROSARCOMA - GENERATION OF T-CELLS IN DRAINING LYMPH-NODES CAPABLE OF TREATING ESTABLISHED PARENTAL METASTATIC TUMOR, Cancer immunology and immunotherapy, 37(5), 1993, pp. 286-292
Risultati: 1-8 |